L. gasseri BNR17.

Lactobacilli carry the fructanase machinery to ferment chicory fructans, so inulin acts as a selective carbon source for the delivered strain. Pairing a strain with its substrate is long-standing synbiotic formulation practice.

Short-chain fructooligosaccharides are fermented in the upper colon by lactic acid bacteria, feeding the strain early in transit. The resulting lactate and acetate lower local pH, which favours lactobacilli over acid-sensitive residents.

Lactobacilli express beta-galactosidase, the same enzyme class that cleaves galactooligosaccharides, so GOS is directly usable by the strain. This is the classic bifidogenic and lactogenic prebiotic pairing.

Partially hydrolysed guar ferments slowly and further along the colon, extending substrate availability beyond what short fructans provide. It also carries a low gas load, which is why it is used alongside strains in sensitive formulas.

Lactobacilli release lactate and acetate that bifidobacteria and downstream butyrate producers consume, so the two genera feed one another's metabolism. Multi-genus blending is standard formulation practice for this reason.

Lactoferrin binds free iron in the gut lumen, and lactobacilli are among the few genera with a low iron requirement, so the competitive balance shifts in their favour. Lactoferrin is used as a co-agent in probiotic formulas on that mechanism.

Activated charcoal adsorbs a wide range of luminal organic material and can bind the fermentable substrates and metabolites a strain depends on. Standard practice is to separate charcoal from any live culture by several hours.

Carvacrol and thymol disrupt bacterial membranes without distinguishing residents from a delivered strain, so a concurrent dose reduces viable lactobacilli. Formulators stagger the two rather than combining them in one capsule.

Ionic silver acts on bacterial membranes and thiol enzymes across genera, which includes the lactic acid bacteria being delivered. Taking the two in the same window works against the point of the strain.

Inulin passes the small intestine undigested because human enzymes cannot cleave its beta-2,1 linkages, arriving in the colon as fermentable substrate. Pairing a defined strain with a fermentable fibre is the definition of a synbiotic. Note that fermentable fibre also produces gas, and tolerance varies a lot between people.

Type 2 and type 3 resistant starch reach the colon intact and are fermented largely to butyrate through cross-feeding chains that start with primary degraders. A lactic acid producing strain contributes lactate that other bacteria convert onward. The interaction runs through the wider community rather than directly.

Psyllium holds water and slows transit, which changes how long a live culture spends in each segment of the gut. It is fermented much less than inulin, so it produces less gas. The pairing is about the environment the strain arrives in.

Oat beta-glucan raises luminal viscosity and is fermented in the colon to short-chain fatty acids. Both effects change the setting a probiotic strain colonises. Viscosity itself also slows gastric emptying, which is a separate physiological effect of the fibre.

Pectin is degraded by colonic bacteria into short-chain fatty acids, mostly acetate and propionate. Supplying it alongside a live strain gives resident and introduced bacteria substrate to work on. Which species benefit depends on the individual's starting community.

Konjac glucomannan forms a very viscous gel with water and is fermented distally. It is used in weight-management formats alongside probiotic strains for that reason. Glucomannan needs to be taken with plenty of fluid because of its swelling behaviour.

Guar gum is broken down by colonic bacteria into short-chain fatty acids, and its partially hydrolysed version is used specifically because it ferments with less gas. Combining it with a defined strain is standard synbiotic construction. Tolerance still varies.

Lactobacilli ferment sugars to lactate, which lactate-utilising species convert onward to butyrate and propionate. Combining a Lactobacillus with a Bifidobacterium is common on that cross-feeding logic and on broader coverage of the gut. Whether either strain persists after supplementation stops is a separate question and generally the answer is that they do not.

Multi-strain products combine lactobacilli that survive gastric acid and bile to different degrees, on the reasoning that a wider set raises the chance some of it arrives viable. Strain-specific effects do not transfer between strains, so a benefit shown for one is not evidence for the blend. The pairing is a formulation choice.

Because S. boulardii is a yeast, it is not susceptible to antibacterial compounds, which is why it is combined with bacterial strains in products intended to be taken through a course of antibacterial therapy. The two occupy different niches. This is formulation logic grounded in basic microbiology.

Colonocytes oxidise butyrate in preference to glucose, and butyrate supplied directly reaches the same cells that fermentation would otherwise feed. A lactate-producing strain contributes to butyrate production indirectly through cross-feeding. Supplying both is a direct and an indirect route to the same molecule.

Glutamine is oxidised by enterocytes to support normal turnover of the intestinal lining, a role distinct from butyrate's in the colon. Pairing it with a live culture addresses the host cell layer and the luminal community separately. This supports normal gut barrier structure rather than acting on any condition.

Zinc is a cofactor for enzymes involved in normal epithelial turnover, and the carnosine complex is formulated to release zinc slowly at the mucosal surface. It is combined with probiotic strains in gut support formulas on that complementary logic. The two act on different targets.

Colostrum contains milk oligosaccharides that some lactic acid bacteria can use as substrate, plus immunoglobulins that bind bacterial surfaces. Both properties make it a plausible partner for a live culture. Oral immunoglobulins are largely digested, which limits how much survives to act.

Calcitriol acting at the vitamin D receptor supports normal expression of tight junction proteins and normal innate immune peptide production in the gut lining. That is a host-side contribution that runs alongside anything a live culture does in the lumen. The two are complementary rather than interacting directly.

Bile salts disrupt bacterial membranes, which is why probiotic strains are screened for bile tolerance before commercialisation. Adding supplemental bile salts at the same time as a live culture raises that stress. Taking the two at different times avoids the question entirely.

Betaine hydrochloride is taken to lower gastric pH, and low pH is exactly what kills the majority of an ingested bacterial dose. Enteric or delayed-release capsules exist because of this. Separating the two, or relying on a protected capsule, is the practical response.

Allicin reacts with bacterial thiol groups and shows activity against a wide range of species in vitro, including lactobacilli. Whether an oral garlic dose reaches the gut lumen at an inhibitory concentration is less certain. The interaction is plausible enough to warrant separating the doses.

Laboratory work reports propolis inhibiting a wide range of bacteria, lactic acid bacteria included. This is an in vitro observation and the luminal concentration after an oral dose is unclear. It is a timing consideration rather than a contraindication.